Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review
Mycophenolate mofetil (MMF) is currently used for prophylaxis of acute rejection in solid organ transplantation. There have been diverging reports regarding an association between MMF and the risk of cytomegalovirus (CMV) infection. We reviewed the main published studies in an attempt to clarify the association between the use of MMF and the risk, frequency and severity of CMV infections. In a search of the Medline database with the terms "mycophenolate" and "cytomegalovir*", 42 articles were found to be relevant; among these, 29 articles were thoroughly analyzed. The first studies on MMF in renal transplantation already showed a tendency towards an association between this drug and the occurrence of CMV disease. Further studies were designed specifically to study this association; with the conclusion that an immunosuppressive regimen containing MMF increases the likelihood of CMV disease. Most studies were performed with kidney transplant recipients. We conclude that the use of MMF apparently increases the incidence of CMV disease in renal transplant patients; however, further studies are needed to confirm this association.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Brazilian Society of Infectious Diseases
2006
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000200011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1413-86702006000200011 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1413-867020060002000112006-07-21Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-reviewSong,Alice Tung WanAbdala,EdsonBonazzi,Patrícia RodriguesBacchella,TelésforoMachado,Marcel Cerqueira César Mycophenolate mofetil cytomegalovirus transplant Mycophenolate mofetil (MMF) is currently used for prophylaxis of acute rejection in solid organ transplantation. There have been diverging reports regarding an association between MMF and the risk of cytomegalovirus (CMV) infection. We reviewed the main published studies in an attempt to clarify the association between the use of MMF and the risk, frequency and severity of CMV infections. In a search of the Medline database with the terms "mycophenolate" and "cytomegalovir*", 42 articles were found to be relevant; among these, 29 articles were thoroughly analyzed. The first studies on MMF in renal transplantation already showed a tendency towards an association between this drug and the occurrence of CMV disease. Further studies were designed specifically to study this association; with the conclusion that an immunosuppressive regimen containing MMF increases the likelihood of CMV disease. Most studies were performed with kidney transplant recipients. We conclude that the use of MMF apparently increases the incidence of CMV disease in renal transplant patients; however, further studies are needed to confirm this association.info:eu-repo/semantics/openAccessBrazilian Society of Infectious DiseasesBrazilian Journal of Infectious Diseases v.10 n.2 20062006-04-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000200011en10.1590/S1413-86702006000200011 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Song,Alice Tung Wan Abdala,Edson Bonazzi,Patrícia Rodrigues Bacchella,Telésforo Machado,Marcel Cerqueira César |
spellingShingle |
Song,Alice Tung Wan Abdala,Edson Bonazzi,Patrícia Rodrigues Bacchella,Telésforo Machado,Marcel Cerqueira César Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
author_facet |
Song,Alice Tung Wan Abdala,Edson Bonazzi,Patrícia Rodrigues Bacchella,Telésforo Machado,Marcel Cerqueira César |
author_sort |
Song,Alice Tung Wan |
title |
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
title_short |
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
title_full |
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
title_fullStr |
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
title_full_unstemmed |
Does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: A mini-review |
title_sort |
does mycophenolate mofetil increase the risk of cytomegalovirus infection in solid organ transplant recipients?: a mini-review |
description |
Mycophenolate mofetil (MMF) is currently used for prophylaxis of acute rejection in solid organ transplantation. There have been diverging reports regarding an association between MMF and the risk of cytomegalovirus (CMV) infection. We reviewed the main published studies in an attempt to clarify the association between the use of MMF and the risk, frequency and severity of CMV infections. In a search of the Medline database with the terms "mycophenolate" and "cytomegalovir*", 42 articles were found to be relevant; among these, 29 articles were thoroughly analyzed. The first studies on MMF in renal transplantation already showed a tendency towards an association between this drug and the occurrence of CMV disease. Further studies were designed specifically to study this association; with the conclusion that an immunosuppressive regimen containing MMF increases the likelihood of CMV disease. Most studies were performed with kidney transplant recipients. We conclude that the use of MMF apparently increases the incidence of CMV disease in renal transplant patients; however, further studies are needed to confirm this association. |
publisher |
Brazilian Society of Infectious Diseases |
publishDate |
2006 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000200011 |
work_keys_str_mv |
AT songalicetungwan doesmycophenolatemofetilincreasetheriskofcytomegalovirusinfectioninsolidorgantransplantrecipientsaminireview AT abdalaedson doesmycophenolatemofetilincreasetheriskofcytomegalovirusinfectioninsolidorgantransplantrecipientsaminireview AT bonazzipatriciarodrigues doesmycophenolatemofetilincreasetheriskofcytomegalovirusinfectioninsolidorgantransplantrecipientsaminireview AT bacchellatelesforo doesmycophenolatemofetilincreasetheriskofcytomegalovirusinfectioninsolidorgantransplantrecipientsaminireview AT machadomarcelcerqueiracesar doesmycophenolatemofetilincreasetheriskofcytomegalovirusinfectioninsolidorgantransplantrecipientsaminireview |
_version_ |
1756416338787565568 |